But analysts note it does have exposure to the subprime mortgage sector and in some ways more so than other banks.

FORBES: Bear Baiting

Analysts note that intraday studies remain bullish, but are close to overbought territory.

FORBES: Euro's Next Move In The Hands Of The Eurogroup

Analysts expect a win there, but analyst Timothy Anderson at Prudential Securities recently issued a note arguing that the risk to Lilly's Zyprexa patent may be higher than many analysts expect.

FORBES: The 'Buy' Case For Bristol-Myers

But on Tuesday, he sent a note to investors saying that Sanofi had gone silent to most investors, analysts and the media, and will remain quiet until it announces its results on Oct. 31.

FORBES: Magazine Article